# Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy

Study · id `cardio:ct-nct03112538` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03112538](<https://clinicaltrials.gov/study/NCT03112538>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03112538

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 118 participants.

## Technical summary

Registry record NCT03112538. Randomized; no masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2018-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 118 participants (planned count; ClinicalTrials.gov record NCT03112538, source copy `cardio:ctgov-nct03112538-2017-04-13`, retrieved 2026-10-26)
- Started: 2016-01 (actual) (ClinicalTrials.gov record NCT03112538, source copy `cardio:ctgov-nct03112538-2017-04-13`, retrieved 2026-10-26)
- Primary completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT03112538, source copy `cardio:ctgov-nct03112538-2017-04-13`, retrieved 2026-10-26)
- Completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT03112538, source copy `cardio:ctgov-nct03112538-2017-04-13`, retrieved 2026-10-26)
- Countries: Malaysia (ClinicalTrials.gov record NCT03112538, source copy `cardio:ctgov-nct03112538-2017-04-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03112538-2017-04-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy
- Condition: Type 2 Diabetes Mellitus
- Intervention (Device): Insulin Pump
- Intervention (Drug): Multiple daily injections of insulin
- Lead sponsor: Clinical Research Centre, Malaysia
- Lead sponsor class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

## Provenance

Content hash: 4b955ae57a0e3c3475bea4af6a30c245cd08ad7c4446eb95d9ccd974a67465b1
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
